Qualitative and Quantitative Heterogeniety in Acquiring Resistance to EGFR Kinase Inhibitors in Lung Cancer

被引：0

作者：

Suda, Kenichi ^{[1
]}

Murakami, Isao ^{[2
]}

Sakai, Kazuko ^{[3
]}

Mizuuchi, Hiroshi ^{[1
]}

Sato, Katsuaki ^{[1
]}

Tomizawa, Kenji ^{[1
]}

Nishio, Kazuto ^{[3
]}

Mitsudomi, Tetsuya ^{[1
]}

机构：

[1] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan

[2] Higashi Hiroshima Med Ctr, Dept Resp Med, Higashihiroshima, Japan

[3] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

T790M mutation; Molecular targeted therapy; EGFR mutation; lung adenocarcinoma;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ORAL42.02

引用

页码：S256 / S257

页数：2

共 50 条

[11] EGFR mutations in non-small cell lung cancer: Classification, characteristics and resistance to third-generation EGFR-tyrosine kinase inhibitors (Review) [J].

Tian, Zhe ;

Cen, Lilan ;

Wei, Feng ;

Dong, Jue ;

Huang, Yulan ;

Han, Yi ;

Wang, Zhibo ;

Deng, Junhua ;

Jiang, Yujie .

ONCOLOGY LETTERS, 2025, 30 (02)

[12] Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis [J].

Xu, Jinhe ;

Xu, Lihuan ;

Wang, Baoshan ;

Kong, Wencui ;

Chen, Ying ;

Yu, Zongyang .

FRONTIERS IN ONCOLOGY, 2022, 11

[13] Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors [J].

Kuiper, Justine L. ;

Smit, Egbert F. .

ONCOLOGY, 2014, 87 (02) :83-94

[14] Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation [J].

Suda, Kenichi ;

Murakami, Isao ;

Yu, Hui ;

Kim, Jihye ;

Ellison, Kim ;

Rivard, Christopher J. ;

Mitsudomi, Tetsuya ;

Hirsch, Fred R. .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) :1015-1020

[15] Tyrosine Kinase Inhibitors in Lung Cancer [J].

Thomas, Anish ;

Rajan, Arun ;

Giaccone, Giuseppe .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (03) :589-+

[16] Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer [J].

Suda, Kenichi ;

Murakami, Isao ;

Obata, Keiko ;

Sakai, Kazuko ;

Fujino, Toshio ;

Koga, Takamasa ;

Ohara, Shuta ;

Hamada, Akira ;

Soh, Junichi ;

Nishio, Kazuto ;

Mitsudomi, Tetsuya .

LUNG CANCER, 2020, 148 :100-104

[17] Lack of response to EGFR tyrosine kinase inhibitors in an amylase-producing lung cancer with a preexisting MET amplification [J].

Nemoto, Kenji ;

Hayashihara, Kenji ;

Oh-ishi, Shuji ;

Nakazawa, Mariko ;

Fujita, Kazutaka ;

Sakurai, Hirofumi ;

Kanazawa, Jun ;

Shih-Yuan, Lin ;

Takaku, Takio ;

Minami, Yuko ;

Saito, Takefumi .

INTERNATIONAL CANCER CONFERENCE JOURNAL, 2015, 4 (04) :236-240

[18] Lack of response to EGFR tyrosine kinase inhibitors in an amylase-producing lung cancer with a preexisting MET amplification [J].

Kenji Nemoto ;

Kenji Hayashihara ;

Shuji Oh-ishi ;

Mariko Nakazawa ;

Kazutaka Fujita ;

Hirofumi Sakurai ;

Jun Kanazawa ;

Lin Shih-Yuan ;

Takio Takaku ;

Yuko Minami ;

Takefumi Saito .

International Cancer Conference Journal, 2015, 4 (4) :236-240

[19] Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations [J].

Kim, Min Hwan ;

Kim, Hye Ryun ;

Cho, Byoung Chul ;

Bae, Mi Kyung ;

Kim, Eun Young ;

Lee, Chang Young ;

Lee, Jae Seok ;

Kang, Dae Ryong ;

Kim, Joo Hang .

LUNG CANCER, 2014, 84 (02) :196-202

[20] HDAC Inhibitors Overcome New Generation EGFR-TKI-Resistance Caused by Homozygous BIM Polymorphism in EGFR Mutant Lung Cancer [J].

Yano, Seiji ;

Tanimoto, Azusa ;

Arai, Shoko ;

Fukuda, Koji ;

Ong, Sin T. ;

Takeuchi, Shinji .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S296-S297

← 1 2 3 4 5 →